These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 29216014)
21. Wearable cardioverter-defibrillator for prevention of sudden cardiac death after infected implantable cardioverter-defibrillator removal: A cost-effectiveness evaluation. Healy CA; Carrillo RG Heart Rhythm; 2015 Jul; 12(7):1565-73. PubMed ID: 25839113 [TBL] [Abstract][Full Text] [Related]
22. A systematic review of decision aids that facilitate elements of shared decision-making in chronic illnesses: a review protocol. Wieringa TH; Kunneman M; Rodriguez-Gutierrez R; Montori VM; de Wit M; Smets EMA; Schoonmade LJ; Spencer-Bonilla G; Snoek FJ Syst Rev; 2017 Aug; 6(1):155. PubMed ID: 28784186 [TBL] [Abstract][Full Text] [Related]
25. Patients' perception of implantable cardioverter defibrillator deactivation at the end of life. Hill L; McIlfatrick S; Taylor B; Dixon L; Harbinson M; Fitzsimons D Palliat Med; 2015 Apr; 29(4):310-23. PubMed ID: 25239128 [TBL] [Abstract][Full Text] [Related]
26. Implantable cardioverter-defibrillators in the elderly: rationale and specific age-related considerations. Barra S; ProvidĂȘncia R; Paiva L; Heck P; Agarwal S Europace; 2015 Feb; 17(2):174-86. PubMed ID: 25480942 [TBL] [Abstract][Full Text] [Related]
28. Putting the "Informed" in the informed consent process for implantable cardioverter-defibrillators: Addressing the needs of the elderly patient. Eiser AR; Kirkpatrick JN; Patton KK; McLain E; Dougherty CM; Beattie JM Pacing Clin Electrophysiol; 2018 Mar; 41(3):312-320. PubMed ID: 29363143 [TBL] [Abstract][Full Text] [Related]
29. Patients' attitudes and perceptions of implantable cardioverter-defibrillators: potential barriers to appropriate primary prophylaxis. Yuhas J; Mattocks K; Gravelin L; Remetz M; Foley J; Fazio R; Lampert R Pacing Clin Electrophysiol; 2012 Oct; 35(10):1179-87. PubMed ID: 22897624 [TBL] [Abstract][Full Text] [Related]
30. The need to modify patient selection to improve the benefits of implantable cardioverter-defibrillator for primary prevention of sudden death in non-ischaemic dilated cardiomyopathy. Disertori M; Quintarelli S; Mazzola S; Favalli V; Narula N; Arbustini E Europace; 2013 Dec; 15(12):1693-701. PubMed ID: 23946316 [TBL] [Abstract][Full Text] [Related]
31. Benefits of the implantable cardioverter-defibrillator. Epstein AE J Am Coll Cardiol; 2008 Sep; 52(14):1122-7. PubMed ID: 18804737 [TBL] [Abstract][Full Text] [Related]
35. [Sudden cardiac death in the youth. Is the new subcutaneous implantable cardioverter defibrillator S-ICD an alternative solution?]. Roche NC; Stefuriac M; Dumitrescu N; Charbonnel A; Godreuil C; Bonnevie L Ann Cardiol Angeiol (Paris); 2015 Feb; 64(1):27-31. PubMed ID: 25281995 [TBL] [Abstract][Full Text] [Related]
36. Shared decision making in oncology practice: what do oncologists need to know? Politi MC; Studts JL; Hayslip JW Oncologist; 2012; 17(1):91-100. PubMed ID: 22234632 [TBL] [Abstract][Full Text] [Related]
37. Development of a measure of decision quality for implantable defibrillators. Knoepke CE; Allen LA; Sepucha K; Masoudi FA; Kutner J; Varosy P; Magid D; Matlock DD Pacing Clin Electrophysiol; 2021 Apr; 44(4):677-684. PubMed ID: 33555044 [TBL] [Abstract][Full Text] [Related]